Quidel | QDEL - Gross Profit On Sales


Quidel reported $223.9M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Abbott USD 6.65B 787M Jun/2026
Agilent USD 990M 44M Mar/2026
Becton, Dickinson and Co. USD 2.32B 161M Jun/2026
Bruker USD 416M 36.2M Jun/2026
Cerus USD 33.33M 8.66M Dec/2024
Charles River Laboratories USD 348.78M 69.47M Jun/2026
Danaher USD 3.61B 20M Jun/2026
Haemonetics USD 202.8M 4.59M Jun/2026
Illumina USD 770M 49M Jun/2026
IQVIA Holdings USD 1.44B 368M Jun/2026
Merit Medical Systems USD 215.17M 30.37M Jun/2026
Mettler Toledo International USD 555.82M 119.62M Mar/2026
Myriad Genetics USD 146.8M 3M Dec/2025
Neogen USD 99M 7.7M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Quidel USD 223.9M 315.7M Jun/2026
Revvity USD 416.87M 29.21M Jun/2026
STAAR Surgical USD 43.74M 34.13M Dec/2025
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Waters USD 490M 52M Jun/2026